ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
TaiGen Biotechnology announces the submission of NDA for Taigexyn to the CFDA
June 02, 2017Taigexyn is a novel broad spectrum antibiotic with excellent efficacy against drug-resistant bacteria available in both oral and intravenous formulations. The oral formulation is already approved for marketing and launched in Taiwan, China and mainland Ch
Pharma Sources Insight January 2025
